Cutaneous T-cell lymphoma (CTCL) is a type of non-Hodgkin lymphoma characterized by the proliferation of T-lymphocytes in the skin. The unspecified nature of this code indicates a lack of specific subtype identification, while the involvement of multiple lymph nodes signifies a more advanced stage of the disease. Accurate coding with ICD-10 Code C84.A8 is crucial for proper diagnosis, documentation, medical billing, and public health reporting, ensuring that patients receive appropriate care and resources.
ICD-10 Code C84.A8 represents Cutaneous T-cell lymphoma, unspecified, with involvement of multiple lymph nodes. This condition is a hematological malignancy that primarily affects the skin but can also involve lymphatic tissues. This code should be used when documenting cases where the specific subtype of CTCL is not identified, and there is evidence of lymph node involvement, which is critical for accurate clinical documentation and billing.
Cutaneous T-cell lymphoma, unspecified, lymph nodes multiple sites, is a malignancy arising from T-lymphocytes that primarily manifests in the skin but can progress to involve lymph nodes. The exact etiology remains unclear, but it is associated with immune dysregulation and environmental factors. Prompt diagnosis and treatment are essential to manage symptoms and prevent disease progression.
In SOAP notes, ICD-10 Code C84.A8 is utilized to document the diagnosis of Cutaneous T-cell lymphoma with unspecified characteristics and multiple lymph node involvement. This code aids in capturing the patient's clinical presentation, guiding treatment decisions, and ensuring accurate billing in both acute and chronic care settings.
ICD-10 Code C84.A8 connects subjective patient-reported symptoms and objective clinical findings to a formal diagnosis of Cutaneous T-cell lymphoma. This code is essential for ensuring continuity of care, supporting appropriate billing practices, and meeting EHR documentation standards.
Management of Cutaneous T-cell lymphoma, unspecified, with multiple lymph node involvement often requires a multidisciplinary approach, including hospitalization for severe cases.


HIPAA-compliant and designed with privacy in mind, your patient’s data is protected. Focus on care while we safeguard your information.
Learn moreICD-10 Code C84.A8 is critical in medical billing, particularly in hospital, emergency room, or infectious disease care settings.
| CPT Code | Description |
|---|---|
| 96413 | Chemotherapy administration, intravenous, push technique. |
| 99214 | Established patient office visit, moderate complexity. |
| 88305 | Pathology examination of tissue, surgical pathology. |
| 96415 | Chemotherapy administration, intravenous, additional hours. |
Common Questions About Using ICD-10 Code C84.A8 for Cutaneous T-cell lymphoma, unsp, lymph nodes mult site
What are the common symptoms of Cutaneous T-cell lymphoma?
Common symptoms include itchy skin lesions, erythematous patches, and swollen lymph nodes. Patients may also experience systemic symptoms such as fever and weight loss.
When should ICD-10 Code C84.A8 be used?
ICD-10 Code C84.A8 should be used when documenting cases of Cutaneous T-cell lymphoma with unspecified subtype and evidence of multiple lymph node involvement.
How does this code impact billing?
Using ICD-10 Code C84.A8 accurately reflects the patient's condition, ensuring appropriate reimbursement for services rendered and compliance with documentation standards.
What treatments are available for this condition?
Treatment options may include topical corticosteroids, phototherapy, and systemic therapies such as chemotherapy or immunotherapy, depending on disease severity.
Clinical Notes
SOAP notes
DAP notes
AI medical notes